GTCM
AGTC

Gyon Technologies Capital Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Gyon Technologies Capital Management’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-18,653
Closed -$91K – 458
2020
Q3 		$91K Buy
+18,653
New +$102K 0.07% 262

Other funds holding AGTC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Gyon Technologies Capital Management's AGTC Position: Q4 2020 in Review

Gyon Technologies Capital Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2020, closing a stake of 18,653 shares — an estimated $91K sold.

Gyon Technologies Capital Management first reported a position in AGTC in Q3 2020 and held it in 1 quarter. The position peaked at $91K in Q3 2020. 66 funds tracked by Wall St. Rank hold AGTC as of Q4 2020.

  • Gyon Technologies Capital Management reported no remaining Applied Genetic Technologies Corporation position as of Q4 2020 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 18,653 Applied Genetic Technologies Corporation shares in Q4 2020, an estimated $91K.
  • Gyon Technologies Capital Management first reported a position in Applied Genetic Technologies Corporation in Q3 2020 and held it in 1 quarter.
  • Gyon Technologies Capital Management's Applied Genetic Technologies Corporation position peaked at $91K in Q3 2020.
  • 66 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2020.

Based on Gyon Technologies Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.